catalyst

A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Ps — primary completion

as of 2026-07-01
Monitor thisAsk about this
at a glance
2023-10-12 · Actual — This event happened.
Synthesized from structured facts only — each point cited above.

Event

What
A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Ps — primary completion
Type
Trial Readout
Date
2023-10-12
Date type
ACTUAL
Phase
Phase 2,PHASE3
This event happened.
relationships
The graph out of here
trial
A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic People With Schizophrenia, Followed by an Open-label Extension Phase
trial